Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis

被引:1538
作者
Sotiriou, C
Wirapati, P
Loi, S
Harris, A
Fox, S
Smeds, J
Nordgren, H
Farmer, P
Praz, V
Haibe-Kains, B
Desmedt, C
Larsimont, D
Cardoso, F
Peterse, H
Nuyten, D
Buyse, M
Van de Vijver, MJ
Bergh, J
Piccart, MT
Delorenzi, M
机构
[1] Univ Libre Bruxelles, Funct Genom & Translat Res Unit, Brussels, Belgium
[2] Univ Libre Bruxelles, Translat Res & Med Oncol Unit, Brussels, Belgium
[3] Univ Libre Bruxelles, Inst Jules Bordet, Machine Learning Grp, Brussels, Belgium
[4] Swiss Inst Expt Canc Res, Natl Ctr Competence Res Mol Oncol, CH-1066 Epalinges, Switzerland
[5] Swiss Inst Bioinformat, CH-1066 Epalinges, Switzerland
[6] Univ Oxford, John Radcliffe Hosp, Oncol Mol Lab, Oxford OX3 9DU, England
[7] Univ Oxford, John Radcliffe Hosp, Mol Angiogenesis Lab, Canc Res UK, Oxford OX3 9DU, England
[8] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England
[9] Karolinska Univ Hosp, Canc Ctr Karolinska, Stockholm, Sweden
[10] Univ Uppsala Hosp, Dept Pathol, S-75185 Uppsala, Sweden
[11] Netherlands Canc Inst, Div Diagnost Oncol, Amsterdam, Netherlands
[12] Netherlands Canc Inst, Div Radiat Oncol, Amsterdam, Netherlands
[13] Int Inst Drug Dev, Brussels, Belgium
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2006年 / 98卷 / 04期
关键词
D O I
10.1093/jnci/djj052
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Histologic grade in breast cancer provides clinically important prognostic information. However, 30%-60% of tumors are classified as histologic grade 2. This grade is associated with an intermediate risk of recurrence and is thus not informative for clinical decision making. We examined whether histologic grade was associated with gene expression profiles of breast cancers and whether such profiles could be used to improve histologic grading. Methods: We analyzed microarray data from 189 invasive breast carcinomas and from three published gene expression datasets from breast carcinomas. We identified differentially expressed genes in a training set of 64 estrogen receptor (ER)-positive tumor samples by comparing expression profiles between histologic grade 3 tumors and histologic grade 1 tumors and used the expression of these genes to define the gene expression grade index. Data from 597 independent tumors were used to evaluate the association between relapse-free survival and the gene expression grade index in a Kaplan-Meier analysis. All statistical tests were two-sided. Results: We identified 97 genes in our training set that were associated with histologic grade; most of these genes were involved in cell cycle regulation and proliferation. In validation datasets, the gene expression grade index was strongly associated with histologic grade 1 and 3 status; however, among histologic grade 2 tumors, the index spanned the values for histologic grade 1-3 tumors. Among patients with histologic grade 2 tumors, a high gene expression grade index was associated with a higher risk of recurrence than a low gene expression grade index (hazard ratio = 3.61, 95% confidence interval = 2.25 to 5.78; P<.001, log-rank test). Conclusions: Gene expression grade index appeared to reclassify patients with histologic grade 2 tumors into two groups with high versus low risks of recurrence. This approach may improve the accuracy of tumor grading and thus its prognostic value.
引用
收藏
页码:262 / 272
页数:11
相关论文
共 27 条
[1]  
[Anonymous], 1993, Resampling-based multiple testing: Examples and methods for P-value adjustment
[2]   A comparison of normalization methods for high density oligonucleotide array data based on variance and bias [J].
Bolstad, BM ;
Irizarry, RA ;
Åstrand, M ;
Speed, TP .
BIOINFORMATICS, 2003, 19 (02) :185-193
[3]   Outcome signature genes in breast cancer: is there a unique set? [J].
Ein-Dor, L ;
Kela, I ;
Getz, G ;
Givol, D ;
Domany, E .
BIOINFORMATICS, 2005, 21 (02) :171-178
[4]  
Elston C W, 2002, Histopathology, V41, P154
[5]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[6]  
Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966
[7]   THE NOTTINGHAM PROGNOSTIC INDEX IN PRIMARY BREAST-CANCER [J].
GALEA, MH ;
BLAMEY, RW ;
ELSTON, CE ;
ELLIS, IO .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (03) :207-219
[8]  
Gruvberger S, 2001, CANCER RES, V61, P5979
[9]  
Hedges L.V., 1985, STAT METHODS META AN, DOI 10.1016/b978-0-08-057065-5.50020-8
[10]  
HOPTON DS, 1989, EUR J SURG ONCOL, V15, P21